[HTML][HTML] Immune-related adverse events associated with immune checkpoint inhibitors: an updated comprehensive disproportionality analysis of the FDA adverse …
C Chen, B Wu, CY Zhang, T Xu - International immunopharmacology, 2021 - Elsevier
Backgrounds Immune-related adverse events were reported in patients treated with immune
checkpoint inhibitors (ICIs). However, with the increasing number of immune-related …
checkpoint inhibitors (ICIs). However, with the increasing number of immune-related …
Immune-related adverse events associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event …
C Chen, B Wu, C Zhang, T Xu - International Immunopharmacology, 2021 - europepmc.org
Methods Disproportionality analysis was used in data mining of the suspected adverse
events after ICIs administration based on the Food and Drug Administration Adverse Event …
events after ICIs administration based on the Food and Drug Administration Adverse Event …
Immune-related adverse events associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event …
C Chen, B Wu, CY Zhang, T Xu - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Backgrounds Immune-related adverse events were reported in patients treated with immune
checkpoint inhibitors (ICIs). However, with the increasing number of immune-related …
checkpoint inhibitors (ICIs). However, with the increasing number of immune-related …